Calls Now Open
2022 ADDF-Harrington and 2023 Harrington UK Rare Disease Programs
August 15, 2016
Cleveland – The Trustees of the Burton D. Morgan Foundation in Hudson Ohio have awarded a grant of $200,000 to the Harrington Discovery Institute at University Hospitals in Cleveland, Ohio to support the Institute’s Innovation Support Center (ISC) and its mission of mentoring physician-scientists to advance novel discoveries into new drugs that improve human health.
The Harrington Discovery Institute provides financial and commercialization support to entrepreneurial physician-scientists to translate their ideas into commercial ventures and new medicines. Harrington Scholars are selected from across the country based on innovative science and its potential to impact patient care and target unmet medical needs. While headquartered in Cleveland, the Harrington Discovery Institute is unique in its disease agnostic approach to fostering “extra-mural R&D.”
The Burton D. Morgan Foundation is dedicated to preserving the private enterprise system and has long supported entrepreneurial education in Northeast Ohio. The Foundation’s grant to the Harrington Discovery Institute will extend these entrepreneurial educational efforts to geographically diverse regions by supporting the ISC’s interactions with the growing network of Harrington Scholars.
“We believe that our grant to the Institute fits with our strategy to build a vibrant economy in Northeast Ohio through innovation and new ventures,” Deborah Hoover, President & CEO, Burton D. Morgan Foundation, explains. “The Harrington Discovery Institute is helping physician-scientists gain expertise in the drug commercialization process and see the possibilities of their ideas.”
“This grant from the Burton D. Morgan Foundation makes an important contribution to our innovation efforts and adds momentum to the growth of our physician-scientist community for which the Harrington Discovery Institute is becoming known,” said Jonathan Stamler, MD, President, the Harrington Discovery Institute and the Robert S. and Sylvia K. Reitman Distinguished Chair in Cardiovascular Innovation at University Hospitals Case Medical Center and Case Western Reserve University School of Medicine. “We are creating an elite cadre of physician-scientists from across the country whose discoveries show exceptional promise of yielding novel therapeutics and new Date August 15, 2016 Contact Paula Darte Phone 216-870-6323 News Release Department of Marketing and Communications 11100 Euclid Avenue Cleveland, OH 44106 classes of drugs, while supporting the growth of biomedical entrepreneurial activity in Northeast Ohio.”
University Hospitals - Cleveland
2012 Harrington Investigators